Truly integrated CMC capabilities fully supporting drug product development and GMP manufacturing from FIH to Phase III clinical development programs
No need to align different sites/providers for development, process transfer and GMP manufacturing: time optimization, risk mitigation, project management expertise
Clinical supply capabilities covering a broad number of dosage forms (for oral and inhalation delivery), and handling compounds up to OEB5 (OEL>0.5 μg/m3)
Small scale commercial manufacturing for niche therapeutic indications (rare diseases/orphan drugs)
